美國居民不適用 XM 服務。

U.S. stocks weekly: Streaking in September



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>RPT-BUZZ-U.S. stocks weekly: Streaking in September</title></head><body>

Repeats from Friday with no changes to text. Updates chart

** S&P 500 .SPX extends winning streak to three weeks, adds 0.6% amid tame inflation data and China stimulus boost .N

** SPX on pace for monthly gain, take that September!

** Dow .DJI and Nasdaq .IXIC also up three consecutive weeks, though the latter still lined up at the velvet rope

** This as benchmark Treasury yield perks up, but can't hold 3-week highs after PCE

** Most sectors fleet of foot: Materials sprint to front of the pack, while Energy and Healthcare stumble

** Materials .SPLRCM surge 3.4%. Copper miners rise as metal hits near 10-week high on China stimulus measures, and country's fiscal spending pledge. Freeport-McMoRan FCX.N vaults 15%. Gold shines bright, but faces big barrier on the charts

** Consumer Discretionary .SPLRCD lifts 1.8%. Casino operators jump on China's stimulus plans. Wynn Resorts WYNN.O and Las Vegas Sands LVS.N top SPX stocks, both up ~22% on week

** Industrials .SPLRCI advance 1.6%. Airlines soar after Southwest Airlines LUV.N lifts Q3 rev forecast

** Tech .SPLRCT rises 1.1%. Chipmakers rally after Micron's MU.O forecast points to steady AI demand. MU notches 18% weekly gain

In contrast, AI server maker Super Micro SMCI.O drops after reported DOJ probe

Semiconductor index .SOX up >4%

** Consumer Staples .SPLRCS tick up 0.1%. Costco COST.O falls after qtrly rev miss, hurt by cautious consumer, lower gas prices

** Financials .SPSY fade 0.5%. Visa V.N trips on report DOJ to file lawsuit over illegal debit card monopoly

** Energy .SPNY down 0.8%. Sector sags on report Saudi Arabia may lift oil output O/R

Crude oil futures: Not looking so well on the charts

** Healthcare .SPXHC retreats 1.1%. Regeneron REGN.O falls as analyst downgrades after federal judge said co can't immediately block U.S. sales of rival Amgen's AMGN.O biosimilar version of eye-care drug Eylea

** Meanwhile, individual Investors pitch tents in the neutral camp

** SPX performance YTD:


(Lance Tupper and Terence Gabriel are Reuters market analysts. The views expressed are their own)

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明